The Ministry of Industry and Information Technology will launch a strong chain supplementary chain operation in the pharmaceutical industry chain

Xinhua News Agency, Beijing, September 14 (Reporter Zhang Xinxin) Zhou Jian, deputy director of the Consumer Products Industry Department of the Ministry of Industry and Information Technology, said on the 14th that it will carry out a strong chain of the pharmaceutical industry chain, focus on weak links, and support upstream and downstream enterprises in the industrial chain Carry out coordinated research and continue to improve key core competitiveness.

Zhou Jian made the above statements at the theme press conference of "Promoting the Consumer Product Industry Industry Added Variety Make -ups" held by the Ministry of Industry and Information Technology on the 14th.

He said that since the 18th National Congress of the Communist Party of China, the foundation of my country's pharmaceutical industry has a stronger foundation, stronger power, and new breakthroughs in industrial innovation.

"We establish the" shortage drug production supply monitoring and early warning platform "to improve the ability of drug supply and guarantee." Zhou Jian said that the Ministry of Industry and Information Technology organized upstream and downstream enterprises to set up a drug supply guarantee consortium, which was identified as the relevant departments determined that the 6 consortia were small as a small small. Variety drugs (shortage medicines) concentrated production base construction units to ensure the stable production and supply of 100 small varieties.

According to the data released at the meeting, in 2021, the value -added of my country's pharmaceutical industry accounted for 4.1%of the entire industrial, realized operating income of 3.4 trillion yuan, and operating income increased by 80.8%compared with 2012. Data from Tianyan Check shows that as of now, there are more than 40,000 pharmaceutical industry companies in my country.

"In response to the recent domestic epidemic, we have strengthened the production scheduling of key medical materials such as new crown virus testing agents, protective supplies. As of now, the weekly production capacity of key production enterprises of antigen detection exceeds 500 million people, and nucleic acid testing key manufacturers Weekly Weekly Weekly Weekly The production capacity of more than 200 million people, the annual production capacity of the new crown virus vaccine exceeds 7 billion doses and the output exceeds 5.5 billion doses, can meet the current needs of the epidemic prevention and control situation. "Said He Yaqiong, the director of the Consumer Products Industry Department of the Ministry of Industry and Information Technology.

Zhou Jian said that the Ministry of Industry and Information Technology will strengthen collaboration with relevant departments to accelerate the industrialization of innovation achievements in the medical field. International cooperation attracts global pharmaceutical innovation elements to gather in China.

- END -